121 related articles for article (PubMed ID: 30716391)
1. Lipid dynamics in LPS-induced neuroinflammation by DESI-MS imaging.
Oliveira-Lima OC; Carvalho-Tavares J; Rodrigues MF; Gomez MV; Oliveira ACP; Resende RR; Gomez RS; Vaz BG; Pinto MCX
Brain Behav Immun; 2019 Jul; 79():186-194. PubMed ID: 30716391
[TBL] [Abstract][Full Text] [Related]
2. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.
Henry CJ; Huang Y; Wynne A; Hanke M; Himler J; Bailey MT; Sheridan JF; Godbout JP
J Neuroinflammation; 2008 May; 5():15. PubMed ID: 18477398
[TBL] [Abstract][Full Text] [Related]
3. TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia.
Burfeind KG; Zhu X; Levasseur PR; Michaelis KA; Norgard MA; Marks DL
Brain Behav Immun; 2018 Oct; 73():364-374. PubMed ID: 29852290
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior.
Burton MD; Sparkman NL; Johnson RW
J Neuroinflammation; 2011 May; 8():54. PubMed ID: 21595956
[TBL] [Abstract][Full Text] [Related]
5. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines.
Henry CJ; Huang Y; Wynne AM; Godbout JP
Brain Behav Immun; 2009 Mar; 23(3):309-17. PubMed ID: 18814846
[TBL] [Abstract][Full Text] [Related]
6. Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling.
Liu X; Nemeth DP; Tarr AJ; Belevych N; Syed ZW; Wang Y; Ismail AS; Reed NS; Sheridan JF; Yajnik AR; Disabato DJ; Zhu L; Quan N
Brain Behav Immun; 2016 May; 54():140-148. PubMed ID: 26812118
[TBL] [Abstract][Full Text] [Related]
7. Ferulic Acid Rescues LPS-Induced Neurotoxicity via Modulation of the TLR4 Receptor in the Mouse Hippocampus.
Rehman SU; Ali T; Alam SI; Ullah R; Zeb A; Lee KW; Rutten BPF; Kim MO
Mol Neurobiol; 2019 Apr; 56(4):2774-2790. PubMed ID: 30058023
[TBL] [Abstract][Full Text] [Related]
8. The opioid antagonist, β-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice.
Davis RL; Stevens CW; Thomas Curtis J
Physiol Behav; 2017 May; 173():52-60. PubMed ID: 28130086
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia.
Yeh CH; Hsieh LP; Lin MC; Wei TS; Lin HC; Chang CC; Hsing CH
PLoS One; 2018; 13(1):e0191070. PubMed ID: 29351316
[TBL] [Abstract][Full Text] [Related]
10. The wake-promoting drug Modafinil prevents motor impairment in sickness behavior induced by LPS in mice: Role for dopaminergic D1 receptor.
Zager A; Brandão WN; Margatho RO; Peron JP; Tufik S; Andersen ML; Kornum BR; Palermo-Neto J
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():468-476. PubMed ID: 28499899
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane reduces lipopolysaccharide-induced proinflammatory markers in hippocampus and liver but does not improve sickness behavior.
Townsend BE; Johnson RW
Nutr Neurosci; 2017 Apr; 20(3):195-202. PubMed ID: 26639573
[TBL] [Abstract][Full Text] [Related]
12. The induction of neuronal death by up-regulated microglial cathepsin H in LPS-induced neuroinflammation.
Fan K; Li D; Zhang Y; Han C; Liang J; Hou C; Xiao H; Ikenaka K; Ma J
J Neuroinflammation; 2015 Mar; 12():54. PubMed ID: 25889123
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of xCT attenuates peripheral and central inflammation and mitigates LPS-induced sickness and depressive-like behavior in mice.
Albertini G; Deneyer L; Ottestad-Hansen S; Zhou Y; Ates G; Walrave L; Demuyser T; Bentea E; Sato H; De Bundel D; Danbolt NC; Massie A; Smolders I
Glia; 2018 Sep; 66(9):1845-1861. PubMed ID: 29693305
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid attenuates lipopolysaccharide-induced sickness behaviour and neuroinflammation in mice.
Basu Mallik S; Mudgal J; Nampoothiri M; Hall S; Dukie SA; Grant G; Rao CM; Arora D
Neurosci Lett; 2016 Oct; 632():218-23. PubMed ID: 27597761
[TBL] [Abstract][Full Text] [Related]
15. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.
Sandiego CM; Gallezot JD; Pittman B; Nabulsi N; Lim K; Lin SF; Matuskey D; Lee JY; O'Connor KC; Huang Y; Carson RE; Hannestad J; Cosgrove KP
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12468-73. PubMed ID: 26385967
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.
Cobourne-Duval MK; Taka E; Mendonca P; Soliman KFA
J Neuroimmunol; 2018 Jul; 320():87-97. PubMed ID: 29759145
[TBL] [Abstract][Full Text] [Related]
17. Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia.
Weng L; Zhang H; Li X; Zhan H; Chen F; Han L; Xu Y; Cao X
Int Immunopharmacol; 2017 Mar; 44():1-8. PubMed ID: 27998743
[TBL] [Abstract][Full Text] [Related]
18. Repeated daily administration of increasing doses of lipopolysaccharide provides a model of sustained inflammation-induced depressive-like behaviour in mice that is independent of the NLRP3 inflammasome.
Wickens RA; Ver Donck L; MacKenzie AB; Bailey SJ
Behav Brain Res; 2018 Oct; 352():99-108. PubMed ID: 28760701
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice.
Sahu P; Mudgal J; Arora D; Kinra M; Mallik SB; Rao CM; Pai KSR; Nampoothiri M
Psychopharmacology (Berl); 2019 Jun; 236(6):1829-1838. PubMed ID: 30666359
[TBL] [Abstract][Full Text] [Related]
20. Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice.
Savignac HM; Couch Y; Stratford M; Bannerman DM; Tzortzis G; Anthony DC; Burnet PWJ
Brain Behav Immun; 2016 Feb; 52():120-131. PubMed ID: 26476141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
